Form 483 re­veals spore con­t­a­m­i­na­tion at a South Ko­re­an man­u­fac­tur­ing site last year

An FDA in­spec­tion found sev­er­al is­sues in­clud­ing spore-re­lat­ed con­t­a­m­i­na­tion in the man­u­fac­tur­ing area at a site in the city of Chun­cheon, South Ko­rea.

The in­spec­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER